Raymond Poincare Hospital — Clinical Trial Site

25 Registered trials

12 Currently recruiting

Organisation

Raymond Poincare Hospital

Location

Garches, France

Identifier

ORG-100030270

Address

104 Boulevard Raymond Poincare, 92380, France

Departments

1901: Unité Neuromusculaire, Département de Neurologie pédiatrique et Unité de Soins Intensifs
Anesthesiology
general intensive care unit
Infectious deseases
Infectious diseases
Maladies infectieuses
Maladies infectieuses - équipe mobile d’antibiothérapie
Neurologie et Réanimation pédiatriques
Neurology
Pediatric intensive care unit and neurology
Réanimation médicale adulte
Service de Médecine Intensive - Réanimation, Médecine Hyperbare
Service de MPR Pôle Handicap-Rééducation
Service de Neuro-Urologie
Service de Neurologie
Service de Réanimation Médicochirurgicale
Service des Maladies Infectieuses
Service des maladies infectieuses et tropicales
Unite Fonctionnelle de Genetique Medicale
Université de Versailles – Saint Quentin en Yvelines Service de Génétique Médicale

Clinical trials at this site (25)

Search interface

E. coli Urinary Tract Infection Study Pending

2023-509777-23-00 Bacterial urinary infection 1
ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi… Pending

2024-515107-19-00 Patients (male or female) ≥18 years old with Detrusor o 5
A study to learn about how safe BAY 3389934 is, its suitable dose, and how it affects the participants with sepsis and coagulopathy Recruiting

2024-515635-30-00 Coagulopathy 3 2026-03-24
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of cipaglucosidase alfa/miglustat in both E… Recruiting

2022-501095-25-01 Pediatric Subjects with Infantile-onset Pompe Disease A 5 2024-11-04
A Phase 2 study of DNTH103 in patients with Generalized Myasthenia Gravis Recruiting

2024-512865-15-00 Generalized Myasthenia Gravis 4 2024-09-03
Dexamethasone for treating severe hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype, an international … Recruiting

2023-508153-12-00 Hospital-acquired pneumonia 5 2024-03-26
A study to evaluate the effect of venglustat tablets on left ventricular mass index in male and female adult participants with Fabry disease Recruiting

2023-509715-91-00 Fabry’s disease 5 2022-05-06
A phase 2, randomized, double-blind study of S-606001 as an add-on to enzyme replacement therapy in patients with late-onset Pompe disease. Recruiting

2025-522146-40-00 Late-onset Pompe disease. 4 2026-02-12
Interventional, multicenter, open-label, randomized, non-comparative trial evaluating the safety, in terms of HBV virological control, of 2 … Recruiting

2023-508634-34-00 co-infected with the HIV-1 and HBV viruses 4 2025-05-14
APEDOC: The role of peripheral afferents in modulating post-stroke central pain Recruiting

2023-504676-17-00 Patients with central neuropathic pain POST stroke 5 2025-01-06
Multicentre randomised double-blind superiority trial with a roll-over phase to evaluate the efficacy of OM-89 vs placebo in reducing antibi… Recruiting

2024-512595-35-00 neurogenic bladder 5 2024-11-21
A randomised phase II placebo-controlled trial of ART plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) vs ART plus… Recruiting

2024-516150-22-00 HIV 4 2024-04-11
RECOVERY Recruiting

2023-507441-29-00 Pneumonia 5 2024-02-29
CUSTOMIZED ANTIBIOTIC TREATMENT DURATION AMONG HOSPITALIZED PATIENTS WITH MODERATELY SEVERE COMMUNITY-ACQUIRED PNEUMONIA [CAT-CAP] Recruiting

2023-504208-27-00 Community-acquired pneumonia 5 2024-02-12
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
Long-term follow-up of patients with spinal muscular atrophy Treated with OAV101 IT or OAV101 IV in Clinical Trials Ended

2024-511707-42-00 Spinal Muscular Atrophy 5 2023-01-05
Safety and Efficacy of ALXN1720 in Adults with Generalized Myasthenia Gravis. Ended

2023-508284-77-00 Generalized Myasthenia Gravis with autoantibodies again 5 2022-11-16
A study to evaluate the effect of venglustat tablets on neuropathic and abdominal pain in male and female participants ≥16 years of age with… Ended

2024-511990-31-00 Fabry Disease 5 2022-06-28
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular A… Ended

2023-506761-65-00 Spinal Muscular Atrophy (SMA) 10 2022-04-08
A study investigating the long-term safety and efficacy of intravenous (IV) ATB200 when Co-administrated with oral AT2221 in adult subjects … Ended

2023-505170-15-00 Adult Subjects With Late Onset Pompe Disease (LOPD) 5 2020-05-15
Study to compare the efficacy and safety of NT 201 (botulinum toxin) with placebo for the treatment of lower limb spasticity caused by strok… Ended

2023-505810-12-00 Lower limb spasticity 5 2019-09-03
A study to determine the long-term safety and tolerability of oral lucerastat in adult subjects with Fabry disease Ended

2024-513884-20-00 Fabry disease 5 2019-03-13
Phase 2 Study of CAL02 plus Standard of Care in Severe Community-Acquired Bacterial Pneumonia (SCABP) Halted

2022-502049-91-00 SEVERE COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (SCABP) 4 2023-09-26
Cohort study of human mpox virus disease Ended

2022-501132-42-00 Monkeypox virus disease 6 2022-08-02